Vicente Capital is joining a growing list of buyers that have gone after personal care companies; its investment in US Dermatology Medical Management is the private equity firm’s third move from its latest $165 million fund.

Specifics were not disclosed and the PE firm states it does typically not make investments in companies greater than $25 million. Calls seeking comment were not returned by press time.

The California-based private equity firm, which tends to make buys on the West Coast, has also invested in South Carolina-based MedBridge Healthcare, a sleep diagnostics service provider, and O2 Science, an Arizona company which provides respiratory home healthcare products.

This time, Vicente Capital is buying it its backyard; US Dermatology is based in Irvine, California.

Jay Ferguson, Alain Rothstein, and David Casares of Vicente Capital Partners will join U.S. Dermatology's board of directors.

The healthcare sector has seen significant interest from private equity buyers lately. Earlier this month, Riverside acquired FairPay Solutions, Inc., a healthcare billing system, and, in a separate transaction, Crioestaminal, a Portugal-based biotechnology company. Also, Cortec Group bought a majority stake in 180 Medical Inc. In addition, Miguel Fernandez, chairman of Florida-based private equity firm MBF Healthcare Partners, committed $100 million in capital to invest in a new managed care healthcare platform, Simply Healthcare Plans, in September.

While the US Dermatology play does not perfectly fit into the personal care space, private equity firms have occasionally popped up as buyers amidst a broader theme of consolidation.